Supriya Lifescience Cash Flow Annual

BSE: 543434 | NSE: SUPRIYA | ISIN: INE07RO01027 | Sector: Biotechnology & Drugs

914.30 +14.55 (1.62%)Updated : 06 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	0.06	-0.11	-16.98	-4.95
Net Changein Cash	-0.29	4.20	-82.63	-70.33
Cash Taxes Paid	61.40	59.18	37.64	28.86
Net Income/ Starting Line	274.78	248.48	165.69	123.49
Total Cash Dividends Paid	-8.05	-6.44	-4.83	-4.83
Changesin Working Capital	-108.90	-97.54	-54.79	-64.50
Cashfrom Operating Activities	185.77	164.68	113.31	66.19
Cash Interest Paid	1.89	1.69	0.55	3.08
Cashfrom Financing Activities	-9.88	-8.23	-22.36	-3.37
Depreciation/ Depletion	28.41	20.44	15.81	11.81
Other Investing Cash Flow Items Total	-23.94	10.13	-27.92	-24.70
Capital Expenditures	-152.23	-162.38	-145.66	-108.44
period Type	-	-	-	-
Non- Cash Items	-8.52	-6.71	-13.41	-4.61
Financing Cash Flow Items	-1.89	-1.69	-0.55	6.41
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-176.17	-152.24	-173.58	-133.15
Issuance( Retirement)of Stock Net	-	0.00	0.00	0.00

*All figures in crores except per share values

Trending Stocks

1,035.00+40.00(4.02%)

2,079.30+29.30(1.43%)

1,246.00+17.00(1.38%)

11,400.00-549.00 (-4.59%)

2,851.05-96.35 (-3.27%)

Related News